Social communication is an emerging target for pharmacotherapy in autism spectrum disorder - a review of the literature on potential agents

Journal of the Canadian Academy of Child and Adolescent Psychiatry

Volumn 23, Issue 1, 2014, Pages 20-30

  Baribeau, Danielle A ^a   Anagnostou, Evdokia ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b University of Toronto   (Canada)

Author keywords

Autistic disorder; Oxytocin; Psychopharmacology; Social behaviour

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACAMPROSATE; ARBACLOFEN; ARGIPRESSIN; BUMETANIDE; CYCLOSERINE; MAVOGLURANT; MEMANTINE; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; OXYTOCIN; STX 107; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; BEHAVIOR THERAPY; CLINICAL TRIAL (TOPIC); COMMUNICATION DISORDER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; EVIDENCE BASED PRACTICE; HUMAN; INTERPERSONAL COMMUNICATION; NONHUMAN; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PSYCHOPHARMACOLOGY; SOCIAL BEHAVIOR; SOCIAL DISABILITY; TREATMENT RESPONSE;

EID: 84893248946     PISSN: 17198429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (103)

1. Abrahams, B. S., & Geschwind, D. H. (2008). Advances in autism genetics: On the threshold of a new neurobiology. Nature Reviews Genetics, 9(5), 341-355.
2. Albers, H. E. (2012). The regulation of social recognition, social communication and aggression: Vasopressin in the social behavior neural network. Hormones and Behavior, 61(3), 283-292.
3. Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89(5), 485-491.
4. Anagnostou, E., Soorya, L., Chaplin, W., Bartz, J., Halpern, D., Wasserman, S.,... Hollander, E. (2012). Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: A randomized controlled trial. Molecular Autism, 3(1), 16.
5. Andari, E., Duhamel, J. R., Zalla, T., Herbrecht, E., Leboyer, M., & Sirigu, A. (2010). Promoting social behavior with oxytocin in highfunctioning autism spectrum disorders. Proceedings of the National Academy of Sciences of the United States of America, 107(9), 4389-4394.
6. th ed.). Arlington, VA: American Psychiatric Publishing.
7. th ed. text revision.). Arlington, VA: American Psychiatric Publishing.
8. Bailey, D. B., Jr., Raspa, M., Olmsted, M., & Holiday, D. B. (2008). Cooccurring conditions associated with FMR1 gene variations: Findings from a national parent survey. American Journal of Medical Genetics Part A, 146A(16), 2060-2069.
9. Baron-Cohen, S., Wheelwright, S., Hill, J., Raste, Y., & Plumb, I. (2001). The "Reading the Mind in the Eyes" Test revised version: A study with normal adults, and adults with Asperger syndrome or high-functioning autism. Journal of Child Psychology and Psychiatry, 42(2), 241-251.
10. Bassett, A. S. (2011). Parental origin, DNA structure, and the schizophrenia spectrum. American Journal of Psychiatry, 168(4), 350-353.
11. Bear, M. F., Huber, K. M., & Warren, S. T. (2004). The mGluR theory of fragile X mental retardation. Trends in Neuroscience, 27(7), 370-377.
12. Berry-Kravis, E. M., Hessl, D., Rathmell, B., Zarevics, P., Cherubini, M., Walton-Bowen, K.,... Hagerman, R. J. (2012). Effects of STX209 (Arbaclofen) on neurobehavioral function in children and adults with Fragile X Syndrome: A randomized, controlled, Phase 2 trial. Science Translational Medicine, 4(152), 152ra127.
13. Bishop-Fitzpatrick, L., Minshew, N. J., & Eack, S. M. (2012). A systematic review of psychosocial interventions for adults with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders, 43(3), 687-694.
14. Bolte, E. E., & Diehl, J. J. (2013). Measurement tools and target symptoms/skills used to assess treatment response for individuals with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders, 43(11), 2491-2501.
15. Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P.,... Carpenter, W. T. (2007). The cognitive and negative dymptoms in dchizophrenia trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments. American Journal of Psychiatry, 164(10), 1593-1602.
16. CDC: Center for Disease Control and Prevention (2012). Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveillance Summaries, 61(3), 1-19.
17. Chadman, K. K., Guariglia, S. R., & Yoo, J. H. (2012). New directions in the treatment of autism spectrum disorders from animal model research. Expert Opinion of Drug Discovery, 7(5), 407-416.
18. Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007). Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability. Journal of Child Neurology, 22(5), 574-579.
19. Cho, M. M., DeVries, A. C., Williams, J. R., & Carter, C. S. (1999). The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behavioral Neuroscience, 113(5), 1071-1079.
20. Coghlan, S., Horder, J., Inkster, B., Mendez, M. A., Murphy, D. G., & Nutt, D. J. (2012). GABA system dysfunction in autism and related disorders: From synapse to symptoms. Neuroscience & Biobehavioral Reviews, 36(9), 2044-2055.
21. Collins, A. L., Ma, D., Whitehead, P. L., Martin, E. R., Wright, H. H., Abramson, R. K.,... Pericak-Vance, M. A. (2006). Investigation of autism and GABA receptor subunit genes in multiple ethnic groups. Neurogenetics, 7(3), 167-174.
22. Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L.,... Reich, W. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33(4), 427-433.
23. Dadds, M. R., Macdonald, E., Cauchi, A., Williams, K., Levy, F., & Brennan, J. (2013). Nasal oxytocin for social deficits in childhood autism: A randomized controlled trial. Journal of Autism and Developmental Disorders, 43, 1-11.
24. Deutsch, S. I., Pepe, G. J., Burket, J. A., Winebarger, E. E., Herndon, A. L., & Benson, A. D. (2012). D-cycloserine improves sociability and spontaneous stereotypic behaviors in 4-week old mice. Brain Research, 1439, 96-107.
25. Domes, G., Steiner, A., Porges, S. W., & Heinrichs, M. (2012). Oxytocin differentially modulates eye gaze to naturalistic social signals of happiness and anger. Psychoneuroendocrinology, 38(7), 1198-1202.
26. Egashira, N., Tanoue, A., Matsuda, T., Koushi, E., Harada, S., Takano, Y.,... Fujiwara, M. (2007). Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice. Behavioral Brain Research, 178(1), 123-127.
27. Erickson, C. A., Early, M., Stigler, K. A., Wink, L. K., Mullett, J. E., & McDougle, C. J. (2011). An open-label naturalistic pilot study of acamprosate in youth with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 21(6), 565-569.
28. Erickson, C. A., Posey, D. J., Stigler, K. A., Mullett, J., Katschke, A. R., & McDougle, C. J. (2007). A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berlin), 191(1), 141-147.
29. Erickson, C. A., Wink, L. K., Ray, B., Early, M. C., Stiegelmeyer, E., Mathieu-Frasier, L.,... McDougle, C. J. (2013). Impact of acamprosate on behavior and brain-derived neurotrophic factor: An open-label study in youth with fragile X syndrome. Psychopharmacology (Berlin), 228(1), 75-84.
30. Fatemi, S. H., Reutiman, T. J., Folsom, T. D., & Thuras, P. D. (2009). GABA(A) receptor downregulation in brains of subjects with autism. Journal of Autism and Developmental Disorders, 39(2), 223-230.
31. Ferguson, J. N., Aldag, J. M., Insel, T. R., & Young, L. J. (2001). Oxytocin in the medial amygdala is essential for social recognition in the mouse. Journal of Neuroscience, 21(20), 8278-8285.
32. Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000). Social amnesia in mice lacking the oxytocin gene. Nature Genetics, 25(3), 284-288.
33. Freeman, B. J., Ritvo, E. R., Yokota, A., Childs, J., & Pollard, J. (1988). WISC-R and Vineland Adaptive Behavior Scale scores in autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 27(4), 428-429.
34. Gandal, M. J., Anderson, R. L., Billingslea, E. N., Carlson, G. C., Roberts, T. P., & Siegel, S. J. (2012). Mice with reduced NMDA receptor expression: More consistent with autism than schizophrenia? Genes, Brain and Behavior, 11(6), 740-750.
35. Gantois, I., Pop, A. S., de Esch, C. E., Buijsen, R. A., Pooters, T., Gomez-Mancilla, B.,... Willemsen, R. (2013). Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice. Behavioral Brain Research, 239, 72-79.
36. Ghaleiha, A., Asadabadi, M., Mohammadi, M. R., Shahei, M., Tabrizi, M., Hajiaghaee, R.,... Akhondzadeh, S. (2012). Memantine as adjunctive treatment to risperidone in children with autistic disorder: A randomized, double-blind, placebo-controlled trial. International Journal of Neuropsychopharmacology, 1-7.
37. Gregory, S. G., Connelly, J. J., Towers, A. J., Johnson, J., Biscocho, D., Markunas, C. A.,... Pericak-Vance, M. A. (2009). Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Medicine, 7, 62.
38. Gresham, F. M., Elliott, S. N., & Kettler, R. J. (2010). Base rates of social skills acquisition/performance deficits, strengths, and problem behaviors: An analysis of the Social Skills Improvement System-Rating Scales. Psychological Assessment, 22(4), 809-815.
39. Guastella, A. J., Einfeld, S. L., Gray, K. M., Rinehart, N. J., Tonge, B. J., Lambert, T. J., & Hickie, I. B. (2010). Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biological Psychiatry, 67(7), 692-694.
40. Guastella, A. J., Mitchell, P. B., & Mathews, F. (2008). Oxytocin enhances the encoding of positive social memories in humans. Biological Psychiatry, 64(3), 256-258.
41. Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007). Reversal of neurological defects in a mouse model of Rett syndrome. Science, 315(5815), 1143-1147.
42. Hall, S. S., Lightbody, A. A., McCarthy, B. E., Parker, K. J., & Reiss, A. L. (2012). Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Psychoneuroendocrinology, 37(4), 509-518.
43. Harris, B. R., Prendergast, M. A., Gibson, D. A., Rogers, D. T., Blanchard, J. A., Holley, R. C.,... Littleton, J. M. (2002). Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcoholism: Clinical and Experimental Research, 26(12), 1779-1793.
44. Henderson, C., Wijetunge, L., Kinoshita, M. N., Shumway, M., Hammond, R. S., Postma, F. R.,... Healy, A. M. (2012). Reversal of disease-related pathologies in the Fragile X Mouse Model by selective activation of GABAB receptors with arbaclofen. Science Translational Medicine, 4(152), 152ra128.
45. Higashida, H., Lopatina, O., Yoshihara, T., Pichugina, Y. A., Soumarokov, A. A., Munesue, T.,... Salmina, A. B. (2010). Oxytocin signal and social behaviour: Comparison among adult and infant oxytocin, oxytocin receptor and CD38 gene knockout mice. Journal of Neuroendocrinology, 22(5), 373-379.
46. Hogart, A., Wu, D., LaSalle, J. M., & Schanen, N. C. (2010). The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiological Disorders, 38(2), 181-191.
47. Hollander, E., Bartz, J., Chaplin, W., Phillips, A., Sumner, J., Soorya, L.,... Wasserman, S. (2007). Oxytocin increases retention of social cognition in autism. Biological Psychiatry, 61(4), 498-503.
48. Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S. (2003). Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology, 28(1), 193-198.
49. Hus, V., Bishop, S., Gotham, K., Huerta, M., & Lord, C. (2013). Factors influencing scores on the social responsiveness scale. Journal of Child Psychology and Psychiatry, 54(2), 216-224.
50. Jacquemont, S., Curie, A., des Portes, V., Torrioli, M. G., Berry-Kravis, E., Hagerman, R. J.,... Gomez-Mancilla, B. (2011). Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Science Translational Medicine, 3(64), 64ra61.
51. Jin, D., Liu, H. X., Hirai, H., Torashima, T., Nagai, T., Lopatina, O.,... Higashida, H. (2007). CD38 is critical for social behaviour by regulating oxytocin secretion. Nature, 446(7131), 41-45.
52. Kaufmann, W. E., Cortell, R., Kau, A. S., Bukelis, I., Tierney, E., Gray, R. M.,... Stanard, P. (2004). Autism spectrum disorder in fragile X syndrome: Communication, social interaction, and specific behaviors. American Journal of Medical Genetics Part A, 129A(3), 225-234.
53. Klaiman, C., Huffman, L., Masaki, L., & Elliott, G. R. (2013). Tetrahydrobiopterin as a treatment for autism spectrum disorders: A double-blind, placebo-controlled trial. Journal of Child and Adolescent Psychopharmacology, 23(5), 320-328.
54. Kosaka, H., Munesue, T., Ishitobi, M., Asano, M., Omori, M., Sato, M.,... Wada, Y. (2012). Long-term oxytocin administration improves social behaviors in a girl with autistic disorder. BMC Psychiatry, 12, 110.
55. Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005). Oxytocin increases trust in humans. Nature, 435(7042), 673-676.
56. Kumar, R. A., & Christian, S. L. (2009). Genetics of autism spectrum disorders. Current Neurology and Neuroscience Reports, 9(3), 188-197.
57. Lemonnier, E., & Ben-Ari, Y. (2010). The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects. Acta Paediatrica, 99(12), 1885-1888.
58. Lemonnier, E., Degrez, C., Phelep, M., Tyzio, R., Josse, F., Grandgeorge, M.,... Ben-Ari, Y. (2012). A randomised controlled trial of bumetanide in the treatment of autism in children. Translational Psychiatry, 2, e202.
59. Lerer, E., Levi, S., Israel, S., Yaari, M., Nemanov, L., Mankuta, D.,... Ebstein, R. P. (2010). Low CD38 expression in lymphoblastoid cells and haplotypes are both associated with autism in a family-based study. Autism Research, 3(6), 293-302.
60. Lerer, E., Levi, S., Salomon, S., Darvasi, A., Yirmiya, N., & Ebstein, R. P. (2008). Association between the oxytocin receptor (OXTR) gene and autism: Relationship to Vineland Adaptive Behavior Scales and cognition. Molecular Psychiatry, 13(10), 980-988.
61. Levenga, J., Hayashi, S., de Vrij, F. M., Koekkoek, S. K., van der Linde, H. C., Nieuwenhuizen, I.,... Oostra, B. A. (2011). AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome. Neurobiological Disorders, 42(3), 311-317.
62. Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Jr., Leventhal, B. L., DiLavore, P. C.,... Rutter, M. (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30(3), 205-223.
63. Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24(5), 659-685.
64. Mann, K., Kiefer, F., Spanagel, R., & Littleton, J. (2008). Acamprosate: Recent findings and future research directions. Alcoholism: Clinical and Experimental Research, 32(7), 1105-1110.
65. Mayer, S., Harris, B., Gibson, D. A., Blanchard, J., Prendergast, M. A., Holley, R. C., & Littleton, J. (2002). Acamprosate has no effect on NMDA-induced toxicity but reduces toxicity induced by spermidine or by changing the medium in organotypic hippocampal slice cultures from rat. Alcoholism: Clinical and Experimental Research, 26(5), 655-662.
66. Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P.,... Ledbetter, D. H. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. The American Journal of Human Genetics, 86(5), 749-764.
67. Modahl, C., Green, L., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998). Plasma oxytocin levels in autistic children. Biological Psychiatry, 43(4), 270-277.
68. Modi, M. E., & Young, L. J. (2011). D-cycloserine facilitates socially reinforced learning in an animal model relevant to autism spectrum disorders. Biological Psychiatry, 70(3), 298-304.
69. Modi, M. E., & Young, L. J. (2012). The oxytocin system in drug discovery for autism: Animal models and novel therapeutic strategies. Hormones and Behavior, 61(3), 340-350.
70. Muddashetty, R. S., Kelic, S., Gross, C., Xu, M., & Bassell, G. J. (2007). Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. Journal of Neuroscience, 27(20), 5338-5348.
71. Nakamoto, M., Nalavadi, V., Epstein, M. P., Narayanan, U., Bassell, G. J., & Warren, S. T. (2007). Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proceedings of the National Academy of Sciences of the United States of America, 104(39), 15537-15542.
72. Neyman, S., & Manahan-Vaughan, D. (2008). Metabotropic glutamate receptor 1 (mGluR1) and 5 (mGluR5) regulate late phases of LTP and LTD in the hippocampal CA1 region in vitro. European Journal of Neuroscience, 27(6), 1345-1352.
73. Niederhofer, H. (2007). Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism. Journal of Clinical Psychopharmacology, 27(3), 317-318.
74. Norris, M., & Lecavalier, L. (2010). Screening accuracy of Level 2 autism spectrum disorder rating scales. A review of selected instruments. Autism, 14(4), 263-284.
75. Nowicki, S., Jr., & Duke, M. P. (1994). Individual differences in the nonverbal communication of affect: The Diagnostic Analysis of Nonverbal Accuracy (DANVA) Scale. Journal of Nonverbal Communication, 18, 9-18.
76. Olmos-Serrano, J. L., Paluszkiewicz, S. M., Martin, B. S., Kaufmann, W. E., Corbin, J. G., & Huntsman, M. M. (2010). Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. Journal of Neuroscience, 30(29), 9929-9938.
77. Owley, T., Salt, J., Guter, S., Grieve, A., Walton, L., Ayuyao, N.,... Cook, E. H., Jr. (2006). A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 16(5), 517-524.
78. Pop, A. S., Levenga, J., de Esch, C. E., Buijsen, R. A., Nieuwenhuizen, I. M., Li, T.,... Willemsen, R. (2012). Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant. Psychopharmacology (Berlin), 110(14), 5671-5676.
79. Posey, D. J., Kem, D. L., Swiezy, N. B., Sweeten, T. L., Wiegand, R. E., & McDougle, C. J. (2004). A pilot study of D-cycloserine in subjects with autistic disorder. American Journal of Psychiatry, 161(11), 2115-2117.
80. Rolf, L. H., Haarmann, F. Y., Grotemeyer, K. H., & Kehrer, H. (1993). Serotonin and amino acid content in platelets of autistic children. Acta Psychiatrica Scandinavica, 87(5), 312-316.
81. Rubenstein, J. L., & Merzenich, M. M. (2003). Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes, Brain and Behavior, 2(5), 255-267.
82. Sala, M., Braida, D., Donzelli, A., Martucci, R., Busnelli, M., Bulgheroni, E.,... Chini, B. (2012). Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) show impaired social behaviour but not increased aggression or cognitive inflexibility: Evidence of a selective haploinsufficiency gene effect. Journal of Neuroendocrinology, 25(2), 107-118.
83. Sansone, S. M., Widaman, K. F., Hall, S. S., Reiss, A. L., Lightbody, A., Kaufmann, W. E.,... Hessl, D. (2012). Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatment. Journal of Autism and Developmental Disorders, 42(7), 1377-1392.
84. Sauer, C., Montag, C., Worner, C., Kirsch, P., & Reuter, M. (2012). Effects of a common variant in the CD38 gene on social processing in an oxytocin challenge study: possible links to autism. Neuropsychopharmacology, 37(6), 1474-1482.
85. Scahill, L., Hallett, V., Aman, M. G., McDougle, C. J., Eugene Arnold, L., McCracken, J. T.,... Vitiello, B. (2013). Brief Report: social disability in autism spectrum disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. Journal of Autism and Developmental Disorders, 43(3), 739-746.
86. Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T.,... Wigler, M. (2007). Strong association of de novo copy number mutations with autism. Science, 316(5823), 445-449.
87. Tachibana, M., Kagitani-Shimono, K., Mohri, I., Yamamoto, T., Sanefuji, W., Nakamura, A.,... Taniike, M. (2013). Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 23(2), 123-127.
88. Thompson, R. R., George, K., Walton, J. C., Orr, S. P., & Benson, J. (2006). Sex-specific influences of vasopressin on human social communication. Proceedings of the National Academy of Sciences of the United States of America, 103(20), 7889-7894.
89. Tobin, V. A., Hashimoto, H., Wacker, D. W., Takayanagi, Y., Langnaese, K., Caquineau, C.,... Ludwig, M. (2010). An intrinsic vasopressin system in the olfactory bulb is involved in social recognition. Nature, 464(7287), 413-417.
90. Tsiouris, J. A., Kim, S. Y., Brown, W. T., Pettinger, J., & Cohen, I. L. (2012). Prevalence of psychotropic drug use in adults with intellectual disability: Positive and negative findings from a large scale study. Journal of Autism and Developmental Disorders, 43(3), 719-731.
91. Van Bourgondien, M. E., Marcus, L. M., & Schopler, E. (1992). Comparison of DSM-III-R and childhood autism rating scale diagnoses of autism. Journal of Autism and Developmental Disorders, 22(4), 493-506.
92. Volker, M. A., Lopata, C., Smerbeck, A. M., Knoll, V. A., Thomeer, M. L., Toomey, J. A., & Rodgers, J. D. (2010). BASC-2 PRS profiles for students with high-functioning autism spectrum disorders. Journal of Autism and Developmental Disorders, 40(2), 188-199.
93. Wei, H., Dobkin, C., Sheikh, A. M., Malik, M., Brown, W. T., & Li, X. (2012). The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome. PLoS One, 7(5), e36981.
94. Wermter, A. K., Kamp-Becker, I., Hesse, P., Schulte-Korne, G., Strauch, K., & Remschmidt, H. (2010). Evidence for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of autistic disorders on high-functioning level. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B(2), 629-639.
95. Williams, J. R., Carter, C. S., & Insel, T. (1992). Partner preference development in female prairie voles is facilitated by mating or the central infusion of oxytocin. Annals of the New York Academy of Sciences, 652, 487-489.
96. Won, H., Lee, H. R., Gee, H. Y., Mah, W., Kim, J. I., Lee, J.,... Kim, E. (2012). Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature, 486(7402), 261-265.
97. Xiao, M. Y., Gustafsson, B., & Niu, Y. P. (2006). Metabotropic glutamate receptors in the trafficking of ionotropic glutamate and GABA(A) receptors at central synapses. Current Neuropharmacology, 4(1), 77-86.
98. Yadav, R., Gupta, S. C., Hillman, B. G., Bhatt, J. M., Stairs, D. J., & Dravid, S. M. (2012). Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors. PLoS One, 7(3), e32969.
99. Yamasue, H. (2012). Function and structure in social brain regions can link oxytocin-receptor genes with autistic social behavior. Brain Development, 35(2), 111-118.
100. Yamasue, H., Yee, J. R., Hurlemann, R., Rilling, J. K., Chen, F. S., Meyer-Lindenberg, A., & Tost, H. (2012). Integrative approaches utilizing oxytocin to enhance prosocial behavior: From animal and human social behavior to autistic social dysfunction. Journal of Neuroscience, 32(41), 14109-14117.
101. Yang, S. Y., Cho, S. C., Yoo, H. J., Cho, I. H., Park, M., Kim, B. N.,... Kim, S. A. (2010). Association study between single nucleotide polymorphisms in promoter region of AVPR1A and Korean autism spectrum disorders. Neuroscience Letters, 479(3), 197-200.
102. Yirmiya, N., Rosenberg, C., Levi, S., Salomon, S., Shulman, C., Nemanov, L.,... Ebstein, R. P. (2006). Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: Mediation by socialization skills. Molecular Psychiatry, 11(5), 488-494.
103. Zink, C. F., & Meyer-Lindenberg, A. (2012). Human neuroimaging of oxytocin and vasopressin in social cognition. Hormones and Behavior, 61(3), 400-409.